Updates in the Management of Multiple Myeloma

Provided by

American Academy of CME, Inc.

Support for this activity has been made possible through an educational grant from Sanofi Genzyme

Release date:
Expiration date:
Estimated time to complete:

Begin Activity

Educational Need

As treatment options and strategies in multiple myeloma (MM) rapidly evolve, oncology nursing professionals will continue to be challenged to manage patients with MM according to the most recent treatment recommendations. Additionally, new agents have adverse event profiles that differ from standard chemotherapy and require new strategies for monitoring and management. Therefore, oncology nursing professionals will benefit from continuing education that assists them in keeping up to date on changes in treatment combinations and sequencing of regimens, as well as enhances their skills managing medication-related adverse effects.


Activity Faculty

Laura J. Zitella, MS, RN, ACNP-BC, AOCN
Nurse Practitioner- Hematology/Oncology
University of California San Francisco, CA


Target Audience

This activity has been designed to meet the educational needs of oncology nurses, nurse practitioners and navigators engaged in the care of patients with multiple myeloma. Other healthcare providers may also participate.

Learning Objectives

After participating in the activity, learners should be better able to:

  Describe the role of new medications in the treatment of MM

Identify adverse events and related nursing management strategies with new medications and combinations used to treat MM

Determine supportive care needs of MM patients considering their medication regimen and co-morbidities

Outline strategies to reduce the risk of skeletal, thrombotic, and infectious complications in MM

Disclosure Statement

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:

Faculty Educator

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

No relevant financial relationships with any commercial interests to report.

Jointly Accredited Provider Accreditation Statement
In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

NPs/Nurses: American Academy of CME, Inc. designates this educational activity for 1.5 ANCC contact hours hours (1.0 pharmacotherapeutic contact hours).

Provider approved by the California Board of Registered Nursing, Provider Number
CEP16993 for 1.5 contact hours.


Other members of the care team will receive a certificate of participation.


Planning Committee

John JD Juchniewicz, MCIS, CHCP, Natalie Kirkwood, RN, BSN, JD (Lead Nurse Planner), Wendy Gloffke, PhD and Paul J. Miniter, MS, American Academy of CME: No relevant financial relationships with any commercial interests.


This activity will not review off-label or investigational information.


The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Method of Participation

There are no fees to participate in the activity.  Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CNE credit for your participation, please complete the post-test and program evaluation. Your certificate will be emailed to you within 24 hours.

Course Viewing Requirements

Supported Browsers:

  • Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

  • Google Chrome 28.0+ for Windows, Mac OS, or Linux

  • Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

  • Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:

  • Android 4.0.3 and above

  • iPhone/iPad with iOS 6.1 or above.

A high-speed Internet connection is recommended.


For more information about the American Academy of CME, Inc. privacy policy, please access http://www.academycme.org/privacy.htm.



For any questions, please contact: CEServices@academycme.org



2021. This CNE-certified activity is held as copyrighted by American Academy of CME, Inc. Through this notice, the Academy  grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).